CellaVision AB (publ)
CLVSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $5 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $4 | $4 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.2% | -1.8% | 4.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.1% | 67.7% | 70.4% | 69.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.6% | 27.2% | 29.6% | 34.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.8% | 19.7% | 21.3% | 21.9% |
| EPS Diluted | 1.31 | 1.58 | 1.74 | 1.72 |
| % Growth | -17.1% | -9.2% | 1.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |